NCT06342271

Effects of Nordic Walking and Free Walking on Arm Swing Parameters and Gait in Parkinson's Disease

Effects of a Nordic Walking Program on Arm Swing Asymmetry and Temporospatial Gait Parameters Compared to Free Walking in People With Parkinson's Disease
University of Talca·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Parkinson Disease
Drug/Device/Intervention
Nordic walking training
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Talca
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Jun 30, 2025
Enrollment
28 participants
Primary outcome

Change in the amplitude of arm swing,Change in the arm swing asymmetry

Summary

People with Parkinson's Disease(PD) present a series of alterations such as muscle stiffness
 and motor slowing, which gradually affect the swinging movement of the arms and legs,
 altering the ability to walk, increasing the risk of falling, and reducing functionality.
 This implies a higher energy cost and a greater probability of developing freezing of the
 gait.
 
 Nordic walking (NW) is a form of physical exercise characterized by the use of walking poles,
 which could contribute positively to arm swing movement and, thus, gait.
 
 This clinical trial aims to compare Nordic Walking with free walking (FW) protocol training
 and investigate their effects on arm swing and gait parameters in people with PD.
 
 The study hypothesizes that NW training will reduce asymmetry and increase arm swing
 amplitudes during gait to a greater extent than FW. Also, improvements in arm swing could
 positively influence lower limb performance during regular gait, increasing gait speed,
 stride length, functional mobility, and quality of life.
 
 People with PD will complete 24 supervised NW or FW training sessions for 12 weeks. Both
 trainings will be identical in volume and intensity, the only difference will be the use of
 poles in the NW group. Blinded researchers will conduct evaluations at baseline (T0),
 post-intervention (T1), and in one-month follow-up (T2).

ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismSecondary parkinsonism, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06342271
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06342271 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Talca and is currently Not yet recruiting. The study focuses on Parkinson Disease. Target enrollment is 28 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.